Jared Gollob, M.D., who headed up clinical development and medical affairs at Alnylam Pharmaceuticals, is joining Kymera Therapeutics, a startup focused on protein degradation. As chief medical officer, Gollob will lead the company’s clinical strategy and organization.
If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.
Accordingly, you can do the same with others as well.